Gitlab Inc.: Form 10-Q for the period ended Jul 31, 2023
Filed with the SEC on Sep 6, 2023 and accepted by EDGAR at Sep 5, 2023, 19:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-05-01 to 2023-07-31 | $139.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-02-01 to 2023-07-31 | $266.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-05-01 to 2023-07-31 | $14.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-02-01 to 2023-07-31 | $28.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-05-01 to 2023-07-31 | $124.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-02-01 to 2023-07-31 | $237.8m | us-gaap:GrossProfit |
| Research and development | 3 months2023-05-01 to 2023-07-31 | $49.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-02-01 to 2023-07-31 | $99.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-05-01 to 2023-07-31 | −$54.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-02-01 to 2023-07-31 | −$112.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-05-01 to 2023-07-31 | $4.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-02-01 to 2023-07-31 | $5.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-05-01 to 2023-07-31 | −$50.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-02-01 to 2023-07-31 | −$102.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-05-01 to 2023-07-31 | −$0.33 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-02-01 to 2023-07-31 | −$0.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-05-01 to 2023-07-31 | −$0.33 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-02-01 to 2023-07-31 | −$0.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-05-01 to 2023-07-31 | 153,644,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-02-01 to 2023-07-31 | 152,683,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-02-01 to 2023-07-31 | $16.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-02-01 to 2023-07-31 | $533.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-07-31 | $273.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-31 | $1.14bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-31 | $1.19bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-31 | $321.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-31 | $357.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-07-31 | $783.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-031433. Last ingested by Listed: Oct 30, 2026, 16:31 ET. Listed shows no prices and gives no investment advice.